Francisco Xavier Galdos

Francisco Xavier Galdos

Auto-generated profile, based on publicly available information

Francisco Xavier Galdos

Stanford University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
JBJan W. Buikema
Jan W. Buikema
SLSoah Lee
Soah Lee
WGWilliam R. Goodyer
William R. Goodyer
RMRenee G. Maas
Renee G. Maas
OCOrlando Chirikian
Orlando Chirikian
Sean WuSean Wu
Sean Wu

17 March 2017 in Circulation Research
Verified
Journal Article
Closed access
PDF file
FGFrancisco X. Galdos
Francisco X. Galdos
YGYuxuan Guo
Yuxuan Guo
SPSharon L. Paige
Sharon L. Paige
NVNathan J. VanDusen
Nathan J. VanDusen
Sean WuSean Wu
Sean Wu
WPWilliam Pu
William Pu
Palliative surgery for congenital heart disease has allowed patients with previously lethal heart malformations to survive and, in most cases, to thrive. However, these procedures often place pressure and volume loads on the heart, and over time, these chronic loads can cause heart failure. Current therapeutic options for initial surgery and chronic heart failure that results from failed palliation are limited, in part, by the mammalian heart’s low inherent capacity to form new cardiomyocytes. Surmounting the heart regeneration barrier would transform the treatment of congenital, as well as acquired, heart disease and likewise would enable development of personalized, in vitro cardiac disease models. Although these remain distant goals, studies of heart development are illuminating the path forward and suggest unique opportunities for heart regeneration, particularly in fetal and neonatal periods. Here, we review major lessons from heart development that inform current and future studies directed at enhancing cardiac regeneration.

7 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
FGFrancisco X. Galdos
Francisco X. Galdos
SXSidra Xu
Sidra Xu
WGWilliam R. Goodyer
William R. Goodyer
LDLauren Duan
Lauren Duan
YHYuhsin V. Huang
Yuhsin V. Huang
Sean WuSean Wu
Sean Wu
A major informatic challenge in single cell RNA-sequencing analysis is the precise annotation of datasets where cells exhibit complex multilayered identities or transitory states. Here, we present devCellPy a highly accurate and precise machine learning-enabled tool that enables automated prediction of cell types across complex annotation hierarchies. To demonstrate the power of devCellPy, we construct a murine cardiac developmental atlas from published datasets encompassing 104,199 cells from E6.5-E16.5 and train devCellPy to generate a cardiac prediction algorithm. Using this algorithm, we observe a high prediction accuracy (>90%) across multiple layers of annotation and across de novo murine developmental data. Furthermore, we conduct a cross-species prediction of cardiomyocyte subtypes from in vitro-derived human induced pluripotent stem cells and unexpectedly uncover a predominance of left ventricular (LV) identity that we confirmed by an LV-specific TBX5 lineage tracing system. Together, our results show devCellPy to be a useful tool for automated cell prediction across complex cellular hierarchies, species, and experimental systems.

7 June 2023 in eLife
Verified
Journal Article
Open access
FGFrancisco X Galdos
Francisco X Galdos
CLCarissa Lee
Carissa Lee
SLSoah Lee
Soah Lee
SPSharon Paige
Sharon Paige
WGWilliam Goodyer
William Goodyer
Sean WuSean Wu
Sean Wu
During mammalian development, the left and right ventricles arise from early populations of cardiac progenitors known as the first and second heart fields, respectively. While these populations have been extensively studied in non-human model systems, their identification and study in vivo human tissues have been limited due to the ethical and technical limitations of accessing gastrulation-stage human embryos. Human-induced pluripotent stem cells (hiPSCs) present an exciting alternative for modeling early human embryogenesis due to their well-established ability to differentiate into all embryonic germ layers. Here, we describe the development of a TBX5/MYL2 lineage tracing reporter system that allows for the identification of FHF- progenitors and their descendants including left ventricular cardiomyocytes. Furthermore, using single-cell RNA sequencing (scRNA-seq) with oligonucleotide-based sample multiplexing, we extensively profiled differentiating hiPSCs across 12 timepoints in two independent iPSC lines. Surprisingly, our reporter system and scRNA-seq analysis revealed a predominance of FHF differentiation using the small molecule Wnt-based 2D differentiation protocol. We compared this data with existing murine and 3D cardiac organoid scRNA-seq data and confirmed the dominance of left ventricular cardiomyocytes (>90%) in our hiPSC-derived progeny. Together, our work provides the scientific community with a powerful new genetic lineage tracing approach as well as a single-cell transcriptomic atlas of hiPSCs undergoing cardiac differentiation.

17 October 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
WGWilliam Rowland Goodyer
William Rowland Goodyer
BBBenjamin M. Beyersdorf
Benjamin M. Beyersdorf
LDLauren Duan
Lauren Duan
NBNynke S. van Den Berg
Nynke S. van Den Berg
SMSruthi Mantri
Sruthi Mantri
Sean WuSean Wu
Sean Wu
Accidental injury to the cardiac conduction system (CCS), a network of specialized cells embedded within the heart and indistinguishable from the surrounding heart muscle tissue, is a major complication in cardiac surgeries. Here, we addressed this unmet need by engineering targeted antibody-dye conjugates directed against the CCS, allowing for the visualization of the CCS in vivo following a single intravenous injection in mice. These optical imaging tools showed high sensitivity, specificity, and resolution, with no adverse effects on CCS function. Further, with the goal of creating a viable prototype for human use, we generated a fully human monoclonal Fab that similarly targets the CCS with high specificity. We demonstrate that, when conjugated to an alternative cargo, this Fab can also be used to modulate CCS biology in vivo, providing a proof of principle for targeted cardiac therapeutics. Finally, in performing differential gene expression analyses of the entire murine CCS at single-cell resolution, we uncovered and validated a suite of additional cell surface markers that can be used to molecularly target the distinct subcomponents of the CCS, each prone to distinct life-threatening arrhythmias. These findings lay the foundation for translational approaches targeting the CCS for visualization and therapy in cardiothoracic surgery, cardiac imaging, and arrhythmia management.

3 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Vahid SerpooshanVahid Serpooshan
Vahid Serpooshan
YLYuan-Hung Liu
Yuan-Hung Liu
JBJan W. Buikema
Jan W. Buikema
FGFrancisco X. Galdos
Francisco X. Galdos
OCOrlando Chirikian
Orlando Chirikian
Sean WuSean Wu
Sean Wu
During normal lifespan, the mammalian heart undergoes limited renewal of cardiomyocytes. While the exact mechanism for this renewal remains unclear, two possibilities have been proposed: differentiated myocyte replication and progenitor/immature cell differentiation. This study aimed to characterize a population of cardiomyocyte precursors in the neonatal heart and to determine their requirement for cardiac development. By tracking the expression of an embryonic Nkx2.5 cardiac enhancer, we identified cardiomyoblasts capable of differentiation into striated cardiomyocytes in vitro. Genome-wide expression profile of neonatal Nkx2.5+ cardiomyoblasts showed the absence of sarcomeric gene and the presence of cardiac transcription factors. To determine the lineage contribution of the Nkx2.5+ cardiomyoblasts, we generated a doxycycline suppressible Cre transgenic mouse under the regulation of the Nkx2.5 enhancer and showed that neonatal Nkx2.5+ cardiomyoblasts mature into cardiomyocytes in vivo. Ablation of neonatal cardiomyoblasts resulted in ventricular hypertrophy and dilation, supporting a functional requirement of the Nkx2.5+ cardiomyoblasts. This study provides direct lineage tracing evidence that a cardiomyoblast population contributes to cardiogenesis in the neonatal heart. The cell population identified here may serve as a promising therapeutic for pediatric cardiac regeneration.